AMBA
AMBA
$78.36-11.30%
Setup
Watch
Buy Zone
$79.15-$83.11
Sector
—
Industry
—
50
Recommendation
Avoid
Avoid
Too many CANSLIM criteria failing.
AMBA chart
Loading chart…
Overall Quality50
RS Rating
51
relative strength
Fundamentals
45
Weak fund-Q
Volume Demand
68
+69% vs avg
Technical Setup
63
5/8 checks
Industry/Theme
91
Computer Software-Enterprise
Trade Plan
Avoid
Entry
$79.15
Entry Zone
$79.15-$83.11
Stop / Risk
$72.82
RS Rating
51
Volume confirmed
No
Targets
$94.98 / $98.94
Breakout · IBD Setup
3 ✓ 5 ✗
Entry $79.15–$83.11Stop $72.82Target $94.98 / $98.94
Market regimeRange
Quality50
RS Rating51
Above 50-MA+6.82%
Above 200-MA+9.4%
VolumeWeak
In Buy ZoneNo
Not extendedOK
Invalidation · Close below stop
How this came together
50
MarketRange
SetupWatch
ConfidenceExperimental · not backtested
Fund-Q45 · Weak
StatusAvoid
Stock Data
52-Week Range48 – 97
Price % Chg YTD10.62%
Price % Chg 4wk-0.03%
50-Day Avg Vol1.4 Mil
P/E Ratio—
Market Cap$375B
Sector—
Industry—
Company Fundamentals
EPS % Chg (Qtr)—
Sales % Chg (Qtr)—
EPS Growth 5y—
Sales Growth 5y—
Annual ROE—
Gross Margin—
Operating Margin—
Net Margin—
Debt / Equity—
Setup levels
Current price
$78.36
Pivot
$79.15
Distance to buy
-19%
52-week range
48.3-96.69
Trigger evidence
No active trigger evidence available.
Financial health checks
0/0
Key metrics
Finviz snapshot · value vs. sector median (≥5 peers)
Annual ROE—
Net margin—
Gross margin—
EPS growth q/q—
Sales growth q/q—
Debt / equity—
lower is better
Business quality
45
GradeWeak
EPS rating50
P/E—
Market cap$375B
Industry—
Technical checks
Über 50-MA
Pass
Über 200-MA
Pass
RS-Linie auf neuem Hoch
Fail
Volumen bestätigt
Fail
In Kaufzone
Fail
Nicht überextended
Pass
Über 21-EMA
Pass
Volumen gesund
Pass
IBD / source mentions
No recent IBD mention found for this ticker.
Signal history
Added to list
2026-06-26
Trigger date
—
Days on list
8
Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.